相似文献
1
Serotyping of Cryptococcus neoformans by dot enzyme assay.
J Clin Microbiol. 1996 Feb;34(2):466-70. doi: 10.1128/jcm.34.2.466-470.1996.
2
Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.
Infect Immun. 1989 Oct;57(10):3240-2. doi: 10.1128/iai.57.10.3240-3242.1989.
3
Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
J Clin Microbiol. 1993 Feb;31(2):359-63. doi: 10.1128/jcm.31.2.359-363.1993.
4
Capsular polysaccharides of Cryptococcus neoformans.
Rev Infect Dis. 1984 Sep-Oct;6(5):619-24. doi: 10.1093/clinids/6.5.619.
5
Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen.
Clin Vaccine Immunol. 2011 Aug;18(8):1292-6. doi: 10.1128/CVI.05052-11. Epub 2011 Jun 22.
6
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
Clin Diagn Lab Immunol. 1998 Mar;5(2):125-9. doi: 10.1128/CDLI.5.2.125-129.1998.
7
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
Infect Immun. 1997 Feb;65(2):718-28. doi: 10.1128/iai.65.2.718-728.1997.
8
Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.
Microbiol Immunol. 1985;29(10):981-91. doi: 10.1111/j.1348-0421.1985.tb02962.x.
9
Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
Infect Immun. 1987 Aug;55(8):1895-9. doi: 10.1128/iai.55.8.1895-1899.1987.
10
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
Infect Immun. 1995 May;63(5):1810-9. doi: 10.1128/iai.63.5.1810-1819.1995.
引用本文的文献
1
Reduced growth and biofilm formation at high temperatures contribute to Cryptococcus deneoformans dermatotropism.
Dis Model Mech. 2025 Sep 1;18(9). doi: 10.1242/dmm.052141. Epub 2025 Mar 25.
2
Molecular Markers Reveal Epidemiological Patterns and Evolutionary Histories of the Human Pathogenic .
Front Cell Infect Microbiol. 2021 May 6;11:683670. doi: 10.3389/fcimb.2021.683670. eCollection 2021.
3
Zinc Finger Proteins in the Human Fungal Pathogen .
Int J Mol Sci. 2020 Feb 18;21(4):1361. doi: 10.3390/ijms21041361.
4
Glucosamine stimulates pheromone-independent dimorphic transition in Cryptococcus neoformans by promoting Crz1 nuclear translocation.
PLoS Genet. 2017 Sep 12;13(9):e1006982. doi: 10.1371/journal.pgen.1006982. eCollection 2017 Sep.
5
Unisexual reproduction reverses Muller's ratchet.
Genetics. 2014 Nov;198(3):1059-69. doi: 10.1534/genetics.114.170472. Epub 2014 Sep 11.
6
Unisexual versus bisexual mating in Cryptococcus neoformans: Consequences and biological impacts.
Fungal Genet Biol. 2015 May;78:65-75. doi: 10.1016/j.fgb.2014.08.008. Epub 2014 Aug 27.
7
Diploids in the Cryptococcus neoformans serotype A population homozygous for the alpha mating type originate via unisexual mating.
PLoS Pathog. 2009 Jan;5(1):e1000283. doi: 10.1371/journal.ppat.1000283. Epub 2009 Jan 30.
8
Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans.
Infect Immun. 2008 Jul;76(7):2923-38. doi: 10.1128/IAI.00168-08. Epub 2008 Apr 21.
9
alpha AD alpha hybrids of Cryptococcus neoformans: evidence of same-sex mating in nature and hybrid fitness.
PLoS Genet. 2007 Oct;3(10):1975-90. doi: 10.1371/journal.pgen.0030186.
10
Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.
J Clin Microbiol. 2004 Jun;42(6):2786-8. doi: 10.1128/JCM.42.6.2786-2788.2004.
本文引用的文献
1
2
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
J Immunol. 1965 Jun;94:916-20.
3
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
Carbohydr Res. 1995 Oct 23;276(2):365-86. doi: 10.1016/0008-6215(95)00167-r.
4
Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
J Clin Microbiol. 1993 Feb;31(2):359-63. doi: 10.1128/jcm.31.2.359-363.1993.
5
Multilocus enzyme typing of Cryptococcus neoformans.
J Clin Microbiol. 1993 Oct;31(10):2819-23. doi: 10.1128/jcm.31.10.2819-2823.1993.
6
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
Infect Immun. 1994 May;62(5):1507-12. doi: 10.1128/iai.62.5.1507-1512.1994.
7
Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans.
J Clin Microbiol. 1994 Jan;32(1):253-5. doi: 10.1128/jcm.32.1.253-255.1994.
8
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.
J Clin Microbiol. 1994 May;32(5):1188-92. doi: 10.1128/jcm.32.5.1188-1192.1994.
9
Molecular typing of Cryptococcus neoformans serotype D clinical isolates.
J Clin Microbiol. 1994 Oct;32(10):2364-71. doi: 10.1128/jcm.32.10.2364-2371.1994.
10
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.
Infect Immun. 1995 May;63(5):1899-905. doi: 10.1128/iai.63.5.1899-1905.1995.
Zotero 插件